|
Market Closed -
Bombay S.E.
06:02:25 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 2,956.95 INR | -0.06% |
|
-4.80% | +19.67% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 30 | 32 | 32 | 42 | 57 | 29.5 | 29.5 |
| Rate of return | 1.8% | 2.42% | 1.65% | 1.46% | 2.5% | 1% | 1% |
| EPS 2 | 100 | 36.05 | 34.83 | 54.76 | 61.15 | 68.78 | 79.18 |
| Distribution rate | 30% | 88.8% | 91.9% | 76.7% | 93.2% | 42.9% | 37.3% |
| Reference price 2 | 1,662.95 | 1,324.15 | 1,943.10 | 2,877.30 | 2,283.40 | 2,956.95 | 2,956.95 |
| Nbr of stocks (in thousands) | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | - |
| Announcement Date | 5/16/22 | 5/17/23 | 5/17/24 | 5/13/25 | 5/13/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: GlaxoSmithKline Pharmaceuticals Limited
| 2026-05-29 | Ex-dividend date - 57 INR | 00:00 |
Upcoming Events: GlaxoSmithKline Pharmaceuticals Limited
| 2026-09-12 | Extraordinary General Meeting | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| Average | ||||||
| Weighted average by Cap. |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
